The University of Chicago Header Logo

Connection

Mark Applebaum to Neoplasm, Residual

Back to Details
This is a "connection" page, showing publications Mark Applebaum has written about Neoplasm, Residual.
Mark Applebaum
Connection Strength
0.047
Neoplasm, Residual
  1. Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.